(Q42980718)

12 November 2017

Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase (English)

1 reference

12 November 2017

Initial Binding of the Broad Spectrum Antiviral Nucleoside Ribavirin to the Hepatitis C Virus RNA Polymerase (English)

1 reference

https://api.crossref.org/works/10.1074/JBC.M308917200

22 March 2024

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1074/JBC.M308917200

22 March 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.M308917200

22 March 2024

author name string

Isabelle Bougie

series ordinal

1

1 reference

12 November 2017

Martin Bisaillon

series ordinal

2

1 reference

12 November 2017

language of work or name

English

0 references

publication date

16 October 2003

1 reference

full work available at URL

12 November 2017

http://www.jbc.org/article/S0021925820752555/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563844

https://api.elsevier.com/content/article/PII:S0021925820752555?httpAccept=text/xml

22 March 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.M308917200

https://api.elsevier.com/content/article/PII:S0021925820752555?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.M308917200

https://syndication.highwire.org/content/doi/10.1074/jbc.M308917200

22 March 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.M308917200

Journal of Biological Chemistry

22 March 2024

published in

1 reference

12 November 2017

278

1 reference

12 November 2017

52

1 reference

12 November 2017

52471-52478

1 reference

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

12 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

The relationship between the metabolism of ribavirin and its proposed mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

The metabolism of ribavirin in erythrocytes and nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

RNA virus error catastrophe: direct molecular test by using ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Hepatitis C: an update on the silent epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Conformational dynamics of DnaB helicase upon DNA and nucleotide binding: analysis by intrinsic tryptophan fluorescence quenching

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Effect of guanine nucleotide binding on the intrinsic tryptophan fluorescence properties of Rab5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Tryptophan fluorescence reports nucleotide-induced conformational changes in a domain of the ArsA ATPase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Structural Analysis of the Hepatitis C Virus RNA Polymerase in Complex with Ribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Crystal structures of active and inactive conformations of a caliciviral RNA-dependent RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

An open and closed case for all polymerases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Characterization of the metal ion binding properties of the hepatitis C virus RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Mechanism of de novo initiation by the hepatitis C virus RNA-dependent RNA polymerase: role of divalent metals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Kinetic mechanism of DNA polymerase I (Klenow).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Kinetic mechanism whereby DNA polymerase I (Klenow) replicates DNA with high fidelity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

NMR studies of conformations and interactions of substrates and ribonucleotide templates bound to the large fragment of DNA polymerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

Hemolytic anemia and the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308917200

A New Class of Synthetic Nucleoside Analogues with Broad-spectrum Antiviral Properties

21 January 2018

series ordinal

37

1 reference

https://api.crossref.org/works/10.1074/JBC.M308917200

22 March 2024

Molecular Pharmacology

39

38

766

Fernandez-Larsson

1990

1 reference

https://api.crossref.org/works/10.1074/JBC.M308917200

22 March 2024

Identifiers

1 reference

12 November 2017

1 reference